AI-Selected News Keywords: 100% Pharmaceutical Tariffs, Retaliatory Tariffs on Imports, US Pressure on Korea Trade
- 100% Pharmaceutical Tariffs: The Trump administration announced a plan to impose tariffs of up to 100% on imports of patented or branded pharmaceuticals if the company does not have manufacturing facilities in the United States.
- Reciprocal / Retaliatory Tariffs: The US is strengthening its strategy of imposing reciprocal or retaliatory tariffs on countries with trade deficits against the US or those maintaining trade barriers.
- US Pressure on Korea Trade: The US is pressuring South Korea in tariff reduction negotiations, even proposing to lower tariffs if Korea commits to investments of around $350 billion. Korea has rejected this proposal.
Overview
The Trump administration is intensifying its use of trade and tariff policies as major weapons of pressure. In particular, the plan to impose 100% tariffs on branded pharmaceutical imports has shocked global pharmaceutical companies and trade partners. At the same time, the US is moving forward with trade pressure and tariff restructuring against key allies, including South Korea. These measures cannot be seen simply as protectionism but as part of a broader diplomatic strategy mixing geopolitical and economic cards.
Announcement of 100% Tariffs on Pharmaceutical Imports
🔗 Read Article
President Trump announced that starting October 1, 2025, imports of patented or branded pharmaceutical products will face tariffs of up to 100%. However, exceptions will be granted if the pharmaceutical company has already begun or is in the process of constructing a factory in the US.
This measure is expected to impose heavy burdens on pharmaceutical-importing countries and global pharmaceutical companies, with some nations already invoking trade agreement provisions to argue for tariff limits.
Adjustment of EU Auto Tariffs and Trade Agreement Implementation
🔗 Read Article
The US officially announced a trade agreement to lower tariffs on European automobiles and auto parts from 25% to 15%, retroactively effective from August 1.
This agreement is seen as a gesture by the Trump administration to ease tariff pressure on some allies, while at the same time maintaining strong tariff policies on other categories such as pharmaceuticals, furniture, and trucks as part of its strategic balance.
US Trade Pressure on Korea and Investment Proposal
🔗 Read Article
The US proposed that if South Korea commits to $350 billion in investments in the US, current tariffs of 25% could be lowered to 15%. However, the Korean government pushed back, arguing that it cannot provide such a large sum all at once and that it poses significant fiscal risks.
Instead, Korea suggested considering structured approaches such as loans, guarantees, or equity investments rather than a direct lump-sum payment.